Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Cosmos Health Inc. announced preliminary record revenue for Q2 and the first half of 2026, with over 31% year-over-year growth, reaching $19.4 million and $37.3 million respectively. The company is actively repurchasing shares under a $5 million buyback program, having bought back 3.64 million shares so far. Cosmos Health continues to expand global…

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

Revolution Medicines announces that the European Medicines Agency (EMA) has started a phased review of its investigational drug daraxonrasib for pancreatic cancer, aiming to accelerate its assessment based on promising Phase 3 trial results. Concurrently, the company is nearing completion of its New Drug Application (NDA) rolling submission to the …

Texxon Holding Limited Announces Commencement of Operations at Henan Polystyrene Production Facility, A Milestone in Manufacturing Expansion Strategy

Texxon Holding Limited Announces Commencement of Operations at Henan Polystyrene Production Facility, A Milestone in Manufacturing Expansion Strategy

Texxon Holding Limited has commenced operations at its new polystyrene production facility in Henan Province, China, marking a key milestone in the company's strategic shift from trading to integrated manufacturing and supply chain services. The facility is strategically located to efficiently serve key manufacturing regions in Central and Northern…

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

Alamar Biosciences has launched the first commercial eMTBR-Tau immunoassay, available as part of the NULISAseq Neuro 220 panel and via a single-plex assay. This blood-based test measures tau tangle burden, a key pathology in Alzheimer's disease, enabling non-invasive detection and monitoring. The platform offers high sensitivity and multiplexing ca…

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program

AIM ImmunoTech Inc. announced a new CEO Corner segment featuring updates from CEO Thomas Equels on the company's advancing DURIPANC Phase 2 clinical trial of Ampligen in combination with AstraZeneca's Imfinzi for pancreatic cancer. The update details completion of patient enrollment and dosing, encouraging interim data, ongoing Phase 3 planning, an…

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

Onconetix, Inc. (Nasdaq: ONCO) announced its pending acquisition of Realbotix LLC, a maker of AI-powered humanoid robots designed for social interaction. Realbotix is partnering with Bloom Procurement Services in the UK to launch an evidence-based pilot using its robots to combat loneliness among elderly residents in care settings in Northeast Engl…

From plastic waste to chocolate wrappers: LYB and Mondelez collaborate on Marabou flexible packaging sourced from recycled plastic

From plastic waste to chocolate wrappers: LYB and Mondelez collaborate on Marabou flexible packaging sourced from recycled plastic

LyondellBasell (LYB) announced a collaboration with Mondelez International and partners to develop innovative flexible packaging for Marabou chocolate bars using CirculenRevive polymers with 100% attributed recycled content. The packaging contains 75% recycled material sourced via a chemical recycling process that transforms hard-to-recycle plastic…

Beyond Meat® to Introduce Beyond Steak® Filet at Meijer This Month

Beyond Meat® to Introduce Beyond Steak® Filet at Meijer This Month

Beyond Meat announced the rollout of Beyond Steak Filet at Meijer stores, expanding its retail presence after successful launches at Wegmans and H-E-B. The plant-based steak filet has been the top-selling product on Beyond Meat's direct-to-consumer platform since its October 2025 debut, praised for taste, texture, and nutritional value. Made with c…

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill

Conexeu Sciences Inc., a preclinical-stage biotech company, announced the completion of its 12-month P.R.O.O.F preclinical study for its CXU™ tissue-restoration platform. The study successfully met facial and large-volume tissue restoration goals and performance benchmarks for injectable aesthetics applications, supporting the company's planned ent…

Silynxcom Successfully Delivers $3 Million Order of Advanced Tactical Communication Solutions to Asian Military Customer

Silynxcom Successfully Delivers $3 Million Order of Advanced Tactical Communication Solutions to Asian Military Customer

Silynxcom Ltd., listed on NYSE American as SYNX, announced the successful delivery of a $3 million order of its flagship tactical in-ear headset systems to a major Asian military customer. This delivery completes the previously announced contract and supports the Company's strategic growth and deeper market penetration in Asia's defense sector, dri…

The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity

The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity

The Oncology Institute, Inc. successfully refinanced its debt by repaying an $86 million senior secured convertible note with Deerfield Partners through a new $75 million term loan from OrbiMed, improving liquidity and extending debt maturities without issuing additional equity. This strategic move enhances the company’s financial flexibility to su…

REalloys and JS Link Sign Non-Binding Strategic Letter of Intent to Develop a Fully Integrated North American Rare Earth Magnet Platform

REalloys and JS Link Sign Non-Binding Strategic Letter of Intent to Develop a Fully Integrated North American Rare Earth Magnet Platform

REalloys Inc. (NASDAQ: ALOY) and JS Link Inc. (KOSDAQ: 127120) have signed a non-binding Letter of Intent to explore a strategic partnership to develop an integrated North American rare earth magnet manufacturing platform. The collaboration aims to combine REalloys' upstream rare earth processing and government relationships with JS Link's advanced…

LPL Research Team Releases Midyear Outlook 2026: Policy-Driven Markets, AI Evolution and the Case for Balance

LPL Research Team Releases Midyear Outlook 2026: Policy-Driven Markets, AI Evolution and the Case for Balance

LPL Financial's Midyear Outlook 2026 report analyzes economic and market conditions for the second half of the year, emphasizing the significant influence of policy decisions, geopolitical risks, and AI-driven earnings growth. The report suggests stable but modest economic growth, continued equity gains tempered by volatility, and steady fixed inco…